Comparison of infectivity and virulence of clones of Trypanosoma evansi and Ttrypanosoma equiperdum Venezuelan strains in mice by Perrone, Trina et al.




Comparison of infectivity and virulence of clones of Trypanosoma evansi and
Ttrypanosoma equiperdum Venezuelan strains in mice
Perrone T.a,b,1, Aso P.M.b, Mijares A.a, Holzmuller P.c, Gonzatti M.b, Parra N.a,⁎
a Laboratorio de Fisiología de Parásitos, Centro de Biofísica y Bioquímica, Instituto Venezolano de Investigaciones Cientíﬁcas, Altos de Pipe, 1020A, Venezuela
bGrupo de Bioquímica e Inmunología de Hemoparásitos, Departamento de Biología Celular, Universidad Simón Bolívar, Caracas 1080, Venezuela
c CIRAD, UMR CIRAD-INRA CMAEE, UMR CIRAD-IRD INTERTRYP, Montpellier, France







A B S T R A C T
Livestock trypanosomoses, caused by three species of the Trypanozoon subgenus, Trypanosoma brucei brucei, T.
evansi and T. equiperdum are widely distributed and limit animal production throughout the world. The in-
fectivity and virulence of clones derived from Trypanosoma evansi and Trypanosoma equiperdum Venezuelan
strains were compared in an in vivo mouse model. Primary infectivity and virulence determinants such as
survival rates, parasitemia levels, PCV, and changes in body weight and survival rates were monitored for up to
32 days. The T. equiperdum strain was the most virulent, with 100% mortality in mice, with the highest para-
sitemia levels (7.0× 107 Tryps/ml) and loss of physical condition. The T. evansi strains induced 100% and 20%
fatality in mice. Our results show that the homogeneous parasite populations maintain the virulent phenotype of
the original T. equiperdum and T. evansi stocks. This is the ﬁrst comparative study of infectivity and virulence
determinants among clonal populations of T. equiperdum and T. evansi.
1. Introduction
Trypanosoma evansi and Trypanosoma equiperdum, are closely re-
lated, distinct parasites, that have been classiﬁed either with the bi-
nomial nomenclature (Hoare, 1972; Desquesnes et al., 2013; Carnes
et al., 2015; Wen et al. 2016) or the trinomial nomenclature (Claes
et al., 2006). T. evansi is a blood and extracellular parasite that causes
equine trypanosomosis, a disease known as Surra in Africa or Derren-
gadera in South America. Traditionally, T. evansi infections have been
observed in domestic and wild animals in acute, sub-acute and chronic
forms, depending on the virulence of the strain and the parasite-host
interplay. Horses and camels, but also donkeys, mules, llamas, dogs,
cats, cattle, and buﬀalo, are susceptible hosts of economic interest
(Desquesnes et al., 2013). Other wild mammals, such as capybaras
(Hydrochoerus hydrochaeris), act as reservoir hosts (Perrone et al.,
2009). The clinical signs of T. evansi infection include anemia, recurrent
fever, weight loss, emaciation, swelling of the hind limbs and hemo-
static abnormalities (Holland et al., 2003; Mekata et al., 2013). T.
equiperdum causes a venereal disease known as Dourine in horses and
donkeys and is morphologically indistinguishable from other Trypano-
zoon species (Verducci et al., 1989; Brun et al., 1998). These host
species appear to be the only natural reservoirs for T. equiperdum. Dogs,
rabbits, rats, and mice are susceptible to experimental infections
(Spickler et al., 2009). Dourine has been found in Africa, Asia, Russia,
Mexico, Southern and Eastern Europe, and several outbreaks in Italy
have been reported in recent years (Dávila and Silva, 2000; Wei et al.,
2011; Calistri et al., 2013; Pascucci et al., 2013, Vulpiani et al., 2013).
Dourine is a serious, often chronic, venereal disease characterized
mainly by swelling of the genitalia, cutaneous plaques, and neurolo-
gical signs. The symptoms vary with the virulence of the strain, the
nutritional status of the host, and stress factors.
Pathogenicity is the aptitude of an organism to produce clinical
signs of diﬀerent severity including mortality and is determined by its
infectivity and virulence. For parasites, virulence depends on the ca-
pacity to multiply inside a host, while infectivity has been deﬁned as
the ability of the microorganism to multiply and be maintained in a
given host (Holzmuller et al., 2008a). Based on the median survival
time, trypanosome virulence has been classiﬁed as extreme, when death
occurs within a week, while high, death within a month, moderate,
death within several months and low, chronic infection and mild or no
clinical signs (Herbert and Parratt, 1979). Comparative virulence stu-
dies of T. evansi isolates from water buﬀaloes have been carried out in
mice (Verdillo et al., 2012). Other authors have reported clear diﬀer-
ences in virulence and/or pathogenicity for T. congolense strains or
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isolates in bovines (Bengaly et al., 2002a,b; Masumu et al., 2006) and in
mice (Bengaly et al., 2002a), for T. brucei gambiense strains in Balb/c
mice (Holzmuller et al., 2008a) and T. congolense and T. evansi in nude
rats (Holzmuller et al., 2008b). The goal of the study was to compare
the infectivity and virulence, in terms of parasitemia levels, clinical
signs and survival rates of mice infected with clones derived from T.
evansi and T. equiperdum strains, that were isolated from three diﬀerent
hosts in Venezuela.
2. Materials and methods
Two T. evansi strains (TeAp-ElFrio01, from capybara and TeGu-
Terecay323, from donkey) and one T. equiperdum strain (TeAp-N/D1,
from horse) were used in this study (Perrone et al., 2009; Sánchez et al.,
2015a,b). To obtain homogenous trypanosome populations, NMRI mice
were immunosuppressed with cyclophosphamide (Endoxan, 300mg/
kg) 48 h prior to infection with 1 trypomastigote/mouse (Smith et al.,
1982). When parasitemia reached 1×106 tryp/ml, mice were bled to
obtain the parasites and two similar passages were performed.
For experimental infections, forty male, 12 weeks old NMRI inbred
mice, were inoculated subcutaneously with 1 trypomastigote/mouse
according to the ethical guidelines of the “Código Nacional de Ética para
La Vida and the Manual de Ética para la Producción y Uso de Animales de
Laboratorio (MPPEUCT-Universidad Central de Venezuela-Facultad de
Ciencias, 2011)”. Parasitemia level, hematocrit %, and body weight
were recorded every two days and compared to the control group. Mice
deaths were registered daily. All experiments were performed in tri-
plicate and the means and standard errors were determined. The ar-
ithmetic means of the infected and the control group were calculated
over the course of the experiment, and analyzed by the non-parametric,
one-way Analysis of Variance (ANOVA); P < 0.05 was considered
signiﬁcant.
3. Results
Mice infected with the T. equiperdum clone showed rapidly in-
creasing parasitemia up to day 8, while the groups infected with the
two T. evansi clones showed lower and ﬂuctuating parasitemias
(Fig. 1a). According to the prepatent periods for each of the strains, the
TeAp-N/D1 clone can be considered as extremely virulent (2 days),
TeAp-ElFrio01 as moderately virulent (5 days) and TeGu-Terecay323 is
a low virulence clone (8 days).
The survival of mice curves presented in Fig. 1b show that the
highest % survival was observed for the T. evansi clone TeGu-Ter-
ecay323 (80%). In contrast, the TeAp-ElFrio01 and T. equiperdum TeAp-
N/D1 clones rendered 100% mortality. Several infectivity and virulence
parameters were evaluated for each strain throughout the mice ex-
perimental infections (Table1).
The development of anemia is shown in Fig. 1c. In the mice infected
with TeAp-ElFrio01, the average hematocrit decreased 15% with re-
spect to the values at the beginning of the infection. In contrast, in the
infection with TeGu-Terecay323, the mean hematocrit decreased by
3%. In mice infected with the TeAp-N/D1, the mean hematocrit de-
creased rapidly and signiﬁcantly (22%) until day 8 post-infection, when
mice died. No anaemia was observed in the control group.
Body weight loss was rapid in mice infected with the T. equiperdum
clone and correlated with its extreme virulence. A decreasing trend in
body weight was observed in the group of mice infected with the
moderately virulent T. evansi. For the low virulent T. evansi clone, no
changes in body weight were observed, and this trend correlated with
the maintenance of hematocrit values
4. Discussion
In order to evaluate the infectivity and virulence of clonal popula-
tions of T. equiperdum and T. evansi, we focused this study on a
parasitological and clinical observation of experimental infection in a
susceptible mice model. The rapid death of the group infected by the T.
equiperdum clone can be attributed to the rapid propagation and high
parasitemia levels that translate into energy requirements that exceed
the capacity of the host. Both T. evansi and T. equiperdum are mainly
extracellular parasites, the success of the infection is based on the
“crosstalk” with the host immune cells through the release of molecules
that play a key role on the course and immunopathology of the disease.
T. brucei gambiense has been shown to promote the release of cytokines
such as tumor necrosis factor (TNF), gamma interferon (IFN-γ) and
interleukins by macrophages (Holzmuller et al., 2008a). In mice in-
fected with T. brucei, these molecules appear to have toxic eﬀects on
the endocrine system of the host (Bosschaerts et al., 2010). Further-
more, IFN-γ produced by CD8+ T cells acts as a growth factor in T.
congolense (Holzmuller et al., 2008a,b). Likewise, T. brucei secretome-
triggered BMDCs inhibit LPS-stimulated production of TNF-α and IL-6
proinﬂammatory cytokines, as well as IL-10. These cytokines are key
mediators of Th1 and Th2 responses and are directly involved in the
induction of an acquired immune response. The decrease of these cy-
tokines favors parasite growth in the host (Garzón et al., 2013).
In the T. equiperdum mice infection, the sharp hematocrit decrease
correlated with high parasitemias and accelerated death. In T. evansi
infections, anemia was observed only in TeAp-ElFrio01. The hematocrit
decrease is the most common feature in infections by Salivarian try-
panosomes and is used as one of the main disease indicators. It has been
described in several hosts of diﬀerent trypanosomes, including sheep,
dogs, coatis and camels (Audu et al., 1999; Reid and Husein, 2001;
Herrera et al., 2002; Masumu et al., 2006). The mechanisms that un-
derlie anemia have not been fully elucidated and the pathogenesis
caused by these trypanosomatids is extremely complex, multifactorial
and appears to include the host response. Several theories have been
proposed to explain the anemia that accompanies animal trypanoso-
mosis caused by T. evansi. According to Juyal (2002), anemia is a
consequence of the host immunological response. They propose that
erythrocytes acquire trypanosome antigens, which triggers an im-
munological reaction and recognition by complement. de Menezes et al.
(2004) propose three alternative hypothesis, hemolysis due to the me-
chanical action of the parasites on the red blood cells, the increase of
endocytosis by spleen cells or intravascular clotting due to micro-
vascular lesions and hemolysis. Dargantes et al. (2005) propose that the
anemia observed in goats infected by T. evansi is caused by the massive
destruction of red blood cells by the mononuclear phagocytic system.
Together with the anemia, observation of body weight, rough hair
coat and behavior are important parameters to be considered in try-
panosome infections. Weight loss in murine models infected with T.
evansi is due to appetite loss, which in turn results in lipid and copper
deﬁciencies (Desquesnes et al., 2013). Lipids are needed for natural
mice hair coat, while lusterless hair coat has been observed in mice
infected with either highly virulent or moderately virulent strains
(Verdillo et al., 2012). In agreement with previous reports of experi-
mental mice and rat T. equiperdum infections, that showed anemia, and
progressive loss of condition, mice infected with the TeAp-N/D1 cloned
strain did not show local oedema of the genitalia, the mammary glands
or oedematous cutaneous eruptions, typical of Dourine (Scacchia et al.,
2011; Hagos et al., 2010). The absence of these clinical signs of Dourine
may be due to the high mortality and virulence of this strain which
results in a very short life for the infected mice.
Biological and pathological features observed upon infection with
the T. equiperdum and T. evansi strains were maintained throughout the
stages of cloning (1, 2 and 3, data not shown) and were consistent with
the infectivity and virulence characteristics of the heterogeneous strains
from which they originated (Holzmuller et al., 2008b). These ﬁndings
suggest that the infectious phenotype appears to be stable in a cloned
population; while plasticity of trypanosome infectivity probably occurs
at the population level due to parasite adaptation during transmission
cycles over the years.
P. T. et al. Veterinary Parasitology 253 (2018) 60–64
61
5. Conclusion
Clones derived from the recently characterized Latin American T.
equiperdum strain TeAp-ND1 maintained the highly virulent and pa-
thological features of the strain, but clinical signs of Dourine were not
shown through the experimental infection since mice died within a
short period, due to the high infectivity of the strain. Some of the
clinical signs in the mice experimentally infected with the T. equiperdum
clone, including anemia, progressive weight loss, and body condition,
were similar to those observed with one of the T. evansi clones (i. e.
TeAp-ElFrio01). On the contrary, the clone from the TeGu-Terecay323
T. evansi strain caused asymptomatic disease, no signiﬁcant alteration
of hematocrit values and very low parasitemias. The diﬀerences in
virulence and infectivity between the T. evansi and T. equiperdum clones
are consistent with the genetic heterogeneity of these species or sub-
species, as reported by Wei et al., 2011; Verdillo et al., 2012;
Fig. 1. a) Average parasitemia in experimental mice infections withTrypanosoma evansi clones (TeAp-ElFrio01 and TeGu-Terecay323) and a Trypanosoma equiperdum clone (TeAp-N/D1).
b) Survival curves of the experimental mice. c) Changes in hematocrit values in mice experimentally infected with clones. NMRI mice were inoculated subcutaneously with 1 trypo-
mastigote of either T. evansi or T. equiperdum cloned strains. A group of non-infected mice was used as control. Mice survival rates were registered daily.
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Desquesnes et al., 2013; Carnes et al., 2015; Sánchez et al., 2015a,b.
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